These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35282272)

  • 21. Rat brain vascular distribution of interleukin-1 type-1 receptor immunoreactivity: relationship to patterns of inducible cyclooxygenase expression by peripheral inflammatory stimuli.
    Konsman JP; Vigues S; Mackerlova L; Bristow A; Blomqvist A
    J Comp Neurol; 2004 Apr; 472(1):113-29. PubMed ID: 15024756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cannabinoid 1 Receptor Signaling on Hippocampal GABAergic Neurons Influences Microglial Activity.
    Ativie F; Komorowska JA; Beins E; Albayram Ö; Zimmer T; Zimmer A; Tejera D; Heneka M; Bilkei-Gorzo A
    Front Mol Neurosci; 2018; 11():295. PubMed ID: 30210289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microglial p38α MAPK is a key regulator of proinflammatory cytokine up-regulation induced by toll-like receptor (TLR) ligands or beta-amyloid (Aβ).
    Bachstetter AD; Xing B; de Almeida L; Dimayuga ER; Watterson DM; Van Eldik LJ
    J Neuroinflammation; 2011 Jul; 8():79. PubMed ID: 21733175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The type 1 interleukin-1 receptor is essential for the efficient activation of microglia and the induction of multiple proinflammatory mediators in response to brain injury.
    Basu A; Krady JK; O'Malley M; Styren SD; DeKosky ST; Levison SW
    J Neurosci; 2002 Jul; 22(14):6071-82. PubMed ID: 12122068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation and Characterization of Mice Expressing a Conditional Allele of the Interleukin-1 Receptor Type 1.
    Robson MJ; Zhu CB; Quinlan MA; Botschner DA; Baganz NL; Lindler KM; Thome JG; Hewlett WA; Blakely RD
    PLoS One; 2016; 11(3):e0150068. PubMed ID: 26930558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulatory effect of IL-1 inhibition following lipopolysaccharide-induced neuroinflammation in neonatal microglia and astrocytes.
    Pierre WC; Londono I; Quiniou C; Chemtob S; Lodygensky GA
    Int J Dev Neurosci; 2022 May; 82(3):243-260. PubMed ID: 35315121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-1 receptor type-1 in non-hematopoietic cells is the target for the pro-atherogenic effects of interleukin-1 in apoE-deficient mice.
    Shemesh S; Kamari Y; Shaish A; Olteanu S; Kandel-Kfir M; Almog T; Grosskopf I; Apte RN; Harats D
    Atherosclerosis; 2012 Jun; 222(2):329-36. PubMed ID: 22236482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-1 primes human mesenchymal stem cells towards an anti-inflammatory and pro-trophic phenotype in vitro.
    Redondo-Castro E; Cunningham C; Miller J; Martuscelli L; Aoulad-Ali S; Rothwell NJ; Kielty CM; Allan SM; Pinteaux E
    Stem Cell Res Ther; 2017 Apr; 8(1):79. PubMed ID: 28412968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Visceral adipose NLRP3 impairs cognition in obesity via IL-1R1 on CX3CR1+ cells.
    Guo DH; Yamamoto M; Hernandez CM; Khodadadi H; Baban B; Stranahan AM
    J Clin Invest; 2020 Apr; 130(4):1961-1976. PubMed ID: 31935195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Three Promoters Regulate Tissue- and Cell Type-specific Expression of Murine Interleukin-1 Receptor Type I.
    Chen Q; Zhang H; Li Q; An Y; Herkenham M; Lai W; Popovich P; Agarwal S; Quan N
    J Biol Chem; 2009 Mar; 284(13):8703-13. PubMed ID: 19196714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postoperative ileus involves interleukin-1 receptor signaling in enteric glia.
    Stoffels B; Hupa KJ; Snoek SA; van Bree S; Stein K; Schwandt T; Vilz TO; Lysson M; Veer CV; Kummer MP; Hornung V; Kalff JC; de Jonge WJ; Wehner S
    Gastroenterology; 2014 Jan; 146(1):176-87.e1. PubMed ID: 24067878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CysLT2 receptor mediates lipopolysaccharide-induced microglial inflammation and consequent neurotoxicity in vitro.
    Chen L; Yang Y; Li CT; Zhang SR; Zheng W; Wei EQ; Zhang LH
    Brain Res; 2015 Oct; 1624():433-445. PubMed ID: 26282348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroprotection by dihydrotestosterone in LPS-induced neuroinflammation.
    Yang L; Zhou R; Tong Y; Chen P; Shen Y; Miao S; Liu X
    Neurobiol Dis; 2020 Jul; 140():104814. PubMed ID: 32087283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel role for protein tyrosine phosphatase 1B as a positive regulator of neuroinflammation.
    Song GJ; Jung M; Kim JH; Park H; Rahman MH; Zhang S; Zhang ZY; Park DH; Kook H; Lee IK; Suk K
    J Neuroinflammation; 2016 Apr; 13(1):86. PubMed ID: 27095436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tanshinone I selectively suppresses pro-inflammatory genes expression in activated microglia and prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson's disease.
    Wang S; Jing H; Yang H; Liu Z; Guo H; Chai L; Hu L
    J Ethnopharmacol; 2015 Apr; 164():247-55. PubMed ID: 25666429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroinflammation and both cytotoxic and vasogenic edema are reduced in interleukin-1 type 1 receptor-deficient mice conferring neuroprotection.
    Lazovic J; Basu A; Lin HW; Rothstein RP; Krady JK; Smith MB; Levison SW
    Stroke; 2005 Oct; 36(10):2226-31. PubMed ID: 16179572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diurnal, age, and immune regulation of interleukin-1β and interleukin-1 type 1 receptor in the mouse suprachiasmatic nucleus.
    Beynon AL; Coogan AN
    Chronobiol Int; 2010 Sep; 27(8):1546-63. PubMed ID: 20854134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microglia-derived IL-1β contributes to axon development disorders and synaptic deficit through p38-MAPK signal pathway in septic neonatal rats.
    Han Q; Lin Q; Huang P; Chen M; Hu X; Fu H; He S; Shen F; Zeng H; Deng Y
    J Neuroinflammation; 2017 Mar; 14(1):52. PubMed ID: 28288671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of interleukin-1 type 1 receptors in lipopolysaccharide-induced sickness responses.
    Matsuwaki T; Shionoya K; Ihnatko R; Eskilsson A; Kakuta S; Dufour S; Schwaninger M; Waisman A; Müller W; Pinteaux E; Engblom D; Blomqvist A
    Brain Behav Immun; 2017 Nov; 66():165-176. PubMed ID: 28655587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of interleukin-1 receptor 1/MyD88 signalling in the development and progression of pulmonary hypertension.
    Parpaleix A; Amsellem V; Houssaini A; Abid S; Breau M; Marcos E; Sawaki D; Delcroix M; Quarck R; Maillard A; Couillin I; Ryffel B; Adnot S
    Eur Respir J; 2016 Aug; 48(2):470-83. PubMed ID: 27418552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.